Compare TWST & FCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TWST | FCN |
|---|---|---|
| Founded | 2013 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 4.6B |
| IPO Year | 2018 | 1996 |
| Metric | TWST | FCN |
|---|---|---|
| Price | $125.21 | $152.68 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 1 |
| Target Price | $46.88 | ★ $165.00 |
| AVG Volume (30 Days) | ★ 1.5M | 383.1K |
| Earning Date | 05-04-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 63.89 | 5.51 |
| EPS | N/A | ★ 3.89 |
| Revenue | $376,572,000.00 | ★ $3,788,857,000.00 |
| Revenue This Year | $18.91 | $7.39 |
| Revenue Next Year | $15.07 | $7.10 |
| P/E Ratio | ★ N/A | $39.29 |
| Revenue Growth | ★ 20.32 | 2.44 |
| 52 Week Low | $23.30 | $137.65 |
| 52 Week High | $125.66 | $189.30 |
| Indicator | TWST | FCN |
|---|---|---|
| Relative Strength Index (RSI) | 70.40 | 43.09 |
| Support Level | $84.39 | $147.45 |
| Resistance Level | N/A | $166.98 |
| Average True Range (ATR) | 8.36 | 5.31 |
| MACD | 3.01 | -1.26 |
| Stochastic Oscillator | 96.18 | 11.23 |
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.
FTI Consulting Inc is a firm that generates its sales by providing professional business advisory services to customers. The company operates through five segments, namely corporate finance, forensic and litigation consulting, economic consulting, technology, and strategic communications. The company generates the majority of its revenue from the Corporate finance segment. Customers of the company come from a wide array of sectors, including construction, energy and power, environmental, financial institutions, healthcare and life science, insurance, real estate and infrastructure, retail and consumer products, telecom, media, and technology. The majority of the company's revenue is derived from serving customers in the United States.